SPONSORED CONTENT
All entities who participate in the 340B program are subject to an Office of Pharmacy Affairs (OPA) audit regardless of entity type, size or volume of transactions. For the last five years, HRSA’s OPA has been completing approximately 200 audits a year and as of May, 2024, 19 audits have been completed. Historically, the entity types at highest risk for audit were disproportionate share hospitals and critical access hospitals, but in the past few years there has been a shift to audit more non-hospital grantees such as Federally Qualified Health Centers, STD clinics, and even specialty clinics. No entity should consider themselves “safe” and all entities should be prepared to receive the dreaded OPA audit notice.
An OPA audit can last anywhere from 2 to 6 months and can include up to five separate phases. The burden is unwieldy – how do you prepare for every aspect of an OPA audit? We
…